-
Multi-omics datasets (WES, RNA-seq) of mesothelioma NERO study, a phase II PARP inhibitor clinical trial
Study
EGAS50000001825
-
Liquid-based genomic profiling in high-risk localized prostate cancer.
Study
EGAS50000001712
-
Smoking-dependent expression alterations in nasal epithelium reveal immune impairment linked to germline variation and lung cancer risk
Study
EGAS00001006137
-
H021-Master Umbrella study2 (not to be released)
Study
EGAS00001005145
-
Comprehensive Characterization of Early Relapse and End-Stage Relapsed Refractory Multiple Myeloma (HIPO K08K/H067/H021+nonHIPO)
Study
EGAS00001007469
-
Deep whole genome ctDNA chronology of treatment-resistant prostate cancer
Study
EGAS00001005783
-
cell-free DNA Target sequencing from primary and recurrent/metastatic breast cancer patients
Study
JGAS000812
-
Development of actionable molecular targets and/or biomarkers for prognostication and patient stratification in gynecological cancer based on whole-exome sequencing and epigenomic analysis
Study
JGAS000813
-
Whole exome sequencing of the dMMR colorectal cancer cohort
Study
EGAS50000001744
-
Smoking-dependent expression alterations in nasal epithelium reveal immune impairment linked to germline variation and lung cancer risk.
Dac
EGAC50000000169